The identification of five different mutations in exon 343 of TTN establishes this exon as the primary target for molecular diagnosis of HMERF and demonstrates the disease is not restricted to Northern Europe.
No takes yet. Share an insight, caveat, or question.
Supports TTN exon 343 sequencing in suspected HMERF; leaves generalizability open pending larger cohorts.
Palmio et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: